查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991520

全球肺計量計市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Spirometer Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 269 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計肺計量計市場將從 2025 年的 9.9 億美元成長到 2034 年的 25.9 億美元，2026 年至 2034 年的複合年成長率為 11.29%。

由於人們對呼吸系統健康的日益關注以及肺部疾病發病率的上升，全球肺計量計市場正顯著成長。肺計量計是醫療設備，透過測量吸氣和呼氣的量和速率來評估肺功能。這些檢查有助於診斷和後續觀察氣喘、慢性阻塞性肺病（COPD）等呼吸系統疾病。

市場成長主要受呼吸系統疾病病例增加的驅動，而呼吸系統疾病病例的增加又與空氣污染、吸菸和人口老化等因素有關。醫療專業人員依靠肺功能儀檢測來評估肺部健康狀況並制定治療方案。此外，攜帶式和數位肺計量計的技術進步提高了其在臨床和居家醫療環境中的可近性和便利性。

隨著醫療系統日益重視呼吸系統疾病的早期檢測和管理，肺計量計市場前景仍然光明。與數位健康平台和行動應用程式的整合有望提升患者監測和數據分析能力。醫療基礎設施的不斷完善和呼吸系統健康意識的提高，預計將推動市場持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球肺計量計市場：依產品類型分類

  • 市場分析、洞察與預測
  • 軟體
  • 設備（桌上型肺計量計、攜帶式肺計量計、連接電腦的肺計量計）
  • 耗材和配件

第5章 全球肺計量計市場：依技術分類

  • 市場分析、洞察與預測
  • 容積式肺計量計
  • 流量測量肺計量計
  • 峰值流量計

第6章：全球肺計量計市場：依機制分類

  • 市場分析、洞察與預測
  • 流量感測式肺計量計
  • 峰值流量計

第7章 全球肺計量計市場：依疾病分類

  • 市場分析、洞察與預測
  • 支氣管炎
  • 氣腫
  • 慢性阻塞性肺病
  • 肺癌
  • 其他

第8章：全球肺計量計市場：以一次性零件分類

  • 市場分析、洞察與預測
  • 篩選
  • 感應器
  • 管子

第9章 全球肺計量計市場：依應用分類

  • 市場分析、洞察與預測
  • 氣喘
  • COPD
  • 囊腫纖維化
  • 肺纖維化
  • 其他

第10章 全球肺計量計市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診所
  • 居家照護

第11章 全球肺計量計市場：依通路分類

  • 市場分析、洞察與預測
  • 一般銷售
  • 直接合約

第12章 全球肺計量計市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第13章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第14章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • F. Hoffmann La Roche Ltd
    • Viatris Inc
    • Pfizer Inc
    • Sanofi SA
    • GSK Plc
    • Novartis AG
    • Bayer AG
    • Merck & Co. Inc
    • AstraZeneca Plc
    • Merck KGaA
    • Cipla Inc
    • LEO Pharma A/S
    • Sun Pharmaceutical Industries Ltd
    • Aurobindo Pharma Ltd
    • Lupin Limited
簡介目錄
Product Code: VMR11214487

The Spirometer Market size is expected to reach USD 2.59 Billion in 2034 from USD 0.99 Billion (2025) growing at a CAGR of 11.29% during 2026-2034.

The global spirometer market has grown significantly due to increasing awareness of respiratory health and the rising prevalence of lung diseases. Spirometers are medical devices used to measure lung function by assessing the amount and speed of air inhaled and exhaled. These tests help diagnose and monitor respiratory conditions such as asthma and chronic obstructive pulmonary disease.

Market growth is driven by increasing cases of respiratory disorders caused by factors such as air pollution, smoking, and aging populations. Healthcare providers rely on spirometry tests to evaluate lung health and guide treatment decisions. Advances in portable and digital spirometers have also improved accessibility and ease of use in clinical and home healthcare settings.

The future outlook for the spirometer market remains promising as healthcare systems emphasize early detection and management of respiratory diseases. Integration with digital health platforms and mobile applications may enhance patient monitoring and data analysis. Expanding healthcare infrastructure and growing respiratory health awareness are expected to support continued market growth.

MARKET SEGMENTATION

By Product Type

  • Software
  • Devices (Table-Top Spirometer, Hand-Held Spirometer, PC Based Spirometer)
  • Consumables and Accessories

By Technology

  • Volume Measurement Spirometer
  • Flow Measurement Spirometer
  • Peak Flow Meter

By Mechanism

  • Flow-Sensing Spirometer
  • Peak Flow Meters

By Disease

  • Bronchitis
  • Emphysema
  • Chronic Obstructive Lung Disease
  • Lung Cancer
  • Others

By Disposable Components

  • Filters
  • Sensors
  • Tubes

By Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Pulmonary Fibrosis
  • Others

By End-User

  • Hospitals
  • Clinics
  • Homecare

By Distribution Channel

  • Over the Counter
  • Direct Tender

COMPANIES PROFILED

  • F Hoffmann La Roche Ltd, Viatris Inc, Pfizer Inc, Sanofi SA, GSK plc, Novartis AG, Bayer AG, Merck Co Inc, AstraZeneca plc, Merck KGaA, Cipla Inc, LEO Pharma AS, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Lupin Limited
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPIROMETER MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Devices (Table-Top Spirometer, Hand-Held Spirometer, PC Based Spirometer) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Consumables and Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPIROMETER MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Volume Measurement Spirometer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Flow Measurement Spirometer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Peak Flow Meter Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPIROMETER MARKET: BY MECHANISM 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Mechanism
  • 6.2. Flow-Sensing Spirometer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Peak Flow Meters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPIROMETER MARKET: BY DISEASE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Disease
  • 7.2. Bronchitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Emphysema Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Chronic Obstructive Lung Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPIROMETER MARKET: BY DISPOSABLE COMPONENTS 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Disposable Components
  • 8.2. Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SPIROMETER MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast Application
  • 9.2. Asthma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. COPD Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Cystic Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.5. Pulmonary Fibrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL SPIROMETER MARKET: BY END-USER 2022-2034 (USD MN)

  • 10.1. Market Analysis, Insights and Forecast End-user
  • 10.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.4. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL SPIROMETER MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 11.1. Market Analysis, Insights and Forecast Distribution Channel
  • 11.2. Over the Counter Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 11.3. Direct Tender Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 12. GLOBAL SPIROMETER MARKET: BY REGION 2022-2034 (USD MN)

  • 12.1. Regional Outlook
  • 12.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 12.2.1 By Product Type
    • 12.2.2 By Technology
    • 12.2.3 By Mechanism
    • 12.2.4 By Disease
    • 12.2.5 By Disposable Components
    • 12.2.6 By Application
    • 12.2.7 By End-user
    • 12.2.8 By Distribution Channel
    • 12.2.9 United States
    • 12.2.10 Canada
    • 12.2.11 Mexico
  • 12.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 12.3.1 By Product Type
    • 12.3.2 By Technology
    • 12.3.3 By Mechanism
    • 12.3.4 By Disease
    • 12.3.5 By Disposable Components
    • 12.3.6 By Application
    • 12.3.7 By End-user
    • 12.3.8 By Distribution Channel
    • 12.3.9 United Kingdom
    • 12.3.10 France
    • 12.3.11 Germany
    • 12.3.12 Italy
    • 12.3.13 Russia
    • 12.3.14 Rest Of Europe
  • 12.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 12.4.1 By Product Type
    • 12.4.2 By Technology
    • 12.4.3 By Mechanism
    • 12.4.4 By Disease
    • 12.4.5 By Disposable Components
    • 12.4.6 By Application
    • 12.4.7 By End-user
    • 12.4.8 By Distribution Channel
    • 12.4.9 India
    • 12.4.10 Japan
    • 12.4.11 South Korea
    • 12.4.12 Australia
    • 12.4.13 South East Asia
    • 12.4.14 Rest Of Asia Pacific
  • 12.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 12.5.1 By Product Type
    • 12.5.2 By Technology
    • 12.5.3 By Mechanism
    • 12.5.4 By Disease
    • 12.5.5 By Disposable Components
    • 12.5.6 By Application
    • 12.5.7 By End-user
    • 12.5.8 By Distribution Channel
    • 12.5.9 Brazil
    • 12.5.10 Argentina
    • 12.5.11 Peru
    • 12.5.12 Chile
    • 12.5.13 Rest of Latin America
  • 12.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 12.6.1 By Product Type
    • 12.6.2 By Technology
    • 12.6.3 By Mechanism
    • 12.6.4 By Disease
    • 12.6.5 By Disposable Components
    • 12.6.6 By Application
    • 12.6.7 By End-user
    • 12.6.8 By Distribution Channel
    • 12.6.9 Saudi Arabia
    • 12.6.10 UAE
    • 12.6.11 Israel
    • 12.6.12 South Africa
    • 12.6.13 Rest of the Middle East And Africa

Chapter 13. COMPETITIVE LANDSCAPE

  • 13.1. Recent Developments
  • 13.2. Company Categorization
  • 13.3. Supply Chain & Channel Partners (based on availability)
  • 13.4. Market Share & Positioning Analysis (based on availability)
  • 13.5. Vendor Landscape (based on availability)
  • 13.6. Strategy Mapping

Chapter 14. COMPANY PROFILES OF GLOBAL SPIROMETER INDUSTRY

  • 14.1. Top Companies Market Share Analysis
  • 14.2. Company Profiles
    • 14.2.1 F. Hoffmann La Roche Ltd
    • 14.2.2 Viatris Inc
    • 14.2.3 Pfizer Inc
    • 14.2.4 Sanofi S.A
    • 14.2.5 GSK Plc
    • 14.2.6 Novartis AG
    • 14.2.7 Bayer AG
    • 14.2.8 Merck & Co. Inc
    • 14.2.9 AstraZeneca Plc
    • 14.2.10 Merck KGaA
    • 14.2.11 Cipla Inc
    • 14.2.12 LEO Pharma A/S
    • 14.2.13 Sun Pharmaceutical Industries Ltd
    • 14.2.14 Aurobindo Pharma Ltd
    • 14.2.15 Lupin Limited